HC Wainwright Issues Negative Outlook for Liquidia Earnings

Liquidia Co. (NASDAQ:LQDA - Free Report) - Investment analysts at HC Wainwright lowered their Q3 2025 earnings per share (EPS) estimates for Liquidia in a note issued to investors on Wednesday, May 28th. HC Wainwright analyst A. Fein now expects that the company will post earnings per share of ($0.33) for the quarter, down from their prior estimate of ($0.30). HC Wainwright currently has a "Buy" rating and a $35.00 target price on the stock. The consensus estimate for Liquidia's current full-year earnings is ($1.51) per share. HC Wainwright also issued estimates for Liquidia's Q4 2025 earnings at ($0.26) EPS, FY2025 earnings at ($1.46) EPS, FY2026 earnings at ($0.53) EPS, FY2027 earnings at $0.07 EPS, FY2028 earnings at $0.48 EPS and FY2029 earnings at $1.44 EPS.

LQDA has been the subject of a number of other reports. Raymond James raised their price objective on Liquidia from $27.00 to $29.00 and gave the stock a "strong-buy" rating in a research report on Friday, May 9th. Oppenheimer set a $13.00 price objective on Liquidia and gave the stock an "underperform" rating in a research report on Monday, May 19th. BTIG Research restated a "buy" rating on shares of Liquidia in a research report on Tuesday. Scotiabank raised their price objective on Liquidia from $36.00 to $37.00 and gave the stock a "sector outperform" rating in a research report on Wednesday. Finally, Wall Street Zen upgraded Liquidia from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, six have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $26.67.

Liquidia Stock Performance

Shares of LQDA traded up $0.03 during mid-day trading on Friday, reaching $15.03. 1,879,582 shares of the company were exchanged, compared to its average volume of 1,087,121. Liquidia has a 52 week low of $8.26 and a 52 week high of $19.41. The stock has a market capitalization of $1.28 billion, a PE ratio of -9.22 and a beta of 0.24. The business has a 50 day simple moving average of $14.71 and a two-hundred day simple moving average of $13.74.

Liquidia (NASDAQ:LQDA - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). Liquidia had a negative return on equity of 163.21% and a negative net margin of 765.38%. The company had revenue of $3.12 million for the quarter, compared to the consensus estimate of $3.23 million.

Insiders Place Their Bets

In other news, insider Jason Adair sold 1,856 shares of the company's stock in a transaction on Monday, April 14th. The stock was sold at an average price of $13.57, for a total transaction of $25,185.92. Following the transaction, the insider now directly owns 184,304 shares of the company's stock, valued at approximately $2,501,005.28. This represents a 1.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Roger Jeffs sold 14,130 shares of the stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $13.57, for a total value of $191,744.10. Following the sale, the chief executive officer now directly owns 1,006,420 shares in the company, valued at $13,657,119.40. This represents a 1.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,138 shares of company stock valued at $450,233 over the last ninety days. 26.50% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of LQDA. DMC Group LLC increased its holdings in shares of Liquidia by 17.4% during the 4th quarter. DMC Group LLC now owns 16,302 shares of the company's stock worth $192,000 after buying an additional 2,419 shares during the last quarter. Catalina Capital Group LLC increased its holdings in Liquidia by 6.5% in the 4th quarter. Catalina Capital Group LLC now owns 18,307 shares of the company's stock valued at $215,000 after purchasing an additional 1,125 shares during the last quarter. Rhumbline Advisers boosted its position in Liquidia by 3.5% in the 4th quarter. Rhumbline Advisers now owns 80,652 shares of the company's stock valued at $948,000 after buying an additional 2,741 shares during the period. Sigma Planning Corp boosted its position in Liquidia by 3.4% in the 4th quarter. Sigma Planning Corp now owns 65,210 shares of the company's stock valued at $767,000 after buying an additional 2,115 shares during the period. Finally, Bank of New York Mellon Corp lifted its position in shares of Liquidia by 3.3% during the 4th quarter. Bank of New York Mellon Corp now owns 188,584 shares of the company's stock worth $2,218,000 after purchasing an additional 6,034 shares during the last quarter. 64.54% of the stock is owned by hedge funds and other institutional investors.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).